Active	Status	Sponsor type	Region	Phase	Filter
2 Active 5 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Aieta, Michele
RAPSON, NCT03230734 / 2016-004452-29: Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer	Active, not recruiting	2	70	Europe	Radium-223, Docetaxel	Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori, Bayer	Metastatic Castration-resistant Prostate Cancer	07/25	07/25
Storto, Giovanni
RAPSON, NCT03230734 / 2016-004452-29: Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer	Active, not recruiting	2	70	Europe	Radium-223, Docetaxel	Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori, Bayer	Metastatic Castration-resistant Prostate Cancer	07/25	07/25